EUVIMEDEUVIMED entdecken
Leserbrief

Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply

Amelia Cecchin, Pravin Hissaria

Pathology · 2023

DOI: 10.1016/j.pathol.2023.09.002 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pathology, 2023. Verfasst von Amelia Cecchin und 1 weiteren Autor:innen. Beteiligte Einrichtung: SA Pathology, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Glutamate Decarboxylase, Nervous System Diseases. Die Arbeit nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutamate DecarboxylaseNervous System DiseasesHumansFluorescent Antibody Technique, IndirectAntibodiesAutoantibodies

Substanzen

Glutamate DecarboxylaseAntibodiesAutoantibodies

Autor:innen und Institutionen

  • SA Pathology, Adelaide, SA, Australia.
  • SA Pathology, Adelaide, SA, Australia; Royal Adelaide Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia. Electronic address: Pravin.Hissaria@sa.gov.au.

Zitieren

APA

Cecchin, A., & Hissaria, P. (2023). Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply. Pathology. https://doi.org/10.1016/j.pathol.2023.09.002

Vancouver

Cecchin A, Hissaria P. Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply. Pathology. 2023. doi:10.1016/j.pathol.2023.09.002

BibTeX
@article{Cecchin2023,
  author = {Cecchin, Amelia and Hissaria, Pravin},
  title = {Indirect immunofluorescence is still relevant in the detection of glutamic acid decarboxylase (GAD) 65 antibody in neurological disease: reply},
  journal = {Pathology},
  year = {2023},
  doi = {10.1016/j.pathol.2023.09.002}
}
Kostenlos starten →